The reported efficacy rates of 94 or 95 percent are for symptomatic disease only. Because the clinical trials for Pfizer and Moderna did not require regular testing for COVID-19, they were not a good indication of how well the vaccine protects against asymptomatic disease (which account for some 40 percent of cases).
原話見內
本帖於 2021-02-01 06:19:50 時間, 由普通用戶 dudaan 編輯